These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 9868523
21. Direct Interaction between the β-Amyloid Core and Tau Facilitates Cross-Seeding: A Novel Target for Therapeutic Intervention. Tripathi T, Khan H. Biochemistry; 2020 Feb 04; 59(4):341-342. PubMed ID: 31944100 [Abstract] [Full Text] [Related]
24. CD40 ligation mediates plaque-associated tau phosphorylation in beta-amyloid overproducing mice. Laporte V, Ait-Ghezala G, Volmar CH, Ganey C, Ganey N, Wood M, Mullan M. Brain Res; 2008 Sep 22; 1231():132-42. PubMed ID: 18606155 [Abstract] [Full Text] [Related]
25. Tau monoclonal antibody generation based on humanized yeast models: impact on Tau oligomerization and diagnostics. Rosseels J, Van den Brande J, Violet M, Jacobs D, Grognet P, Lopez J, Huvent I, Caldara M, Swinnen E, Papegaey A, Caillierez R, Buée-Scherrer V, Engelborghs S, Lippens G, Colin M, Buée L, Galas MC, Vanmechelen E, Winderickx J. J Biol Chem; 2015 Feb 13; 290(7):4059-74. PubMed ID: 25540200 [Abstract] [Full Text] [Related]
26. Alzheimer's plaques and tangles revealed by 3D microscopy. Scheres SHW. Nature; 2024 Jul 13; 631(8022):747-748. PubMed ID: 38987332 [No Abstract] [Full Text] [Related]
28. Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles. Mesulam MM. Neuron; 1999 Nov 13; 24(3):521-9. PubMed ID: 10595506 [No Abstract] [Full Text] [Related]
30. Antineurofibrillary tangle, antineural and anti-beta-amyloid-protein in Alzheimer's disease and related disorders. Gaskin F, Fu SM. Res Immunol; 1992 Nov 13; 143(6):668-70. PubMed ID: 1455059 [No Abstract] [Full Text] [Related]
31. Tau protein, the main component of paired helical filaments. Avila J. J Alzheimers Dis; 2006 Nov 13; 9(3 Suppl):171-5. PubMed ID: 16914856 [Abstract] [Full Text] [Related]
32. Combined analysis of CSF betaA42 peptide and tau protein and serum antibodies to glycosaminoglycans in Alzheimer's disease: preliminary data. Briani C, Ruggero S, Naccarato M, Cagnin A, Ricchieri GL, Pasqui L, Pizzolato G, Battistin L. J Neural Transm (Vienna); 2002 Mar 13; 109(3):393-8. PubMed ID: 11956959 [Abstract] [Full Text] [Related]
37. Direct determination of the proportion of intra- and extra-cellular neocortical neurofibrillary tangles in Alzheimer's disease. Vickers JC, Tan A, Dickson TC. Brain Res; 2003 May 02; 971(1):135-7. PubMed ID: 12691846 [Abstract] [Full Text] [Related]
38. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. Browne TC, McQuillan K, McManus RM, O'Reilly JA, Mills KH, Lynch MA. J Immunol; 2013 Mar 01; 190(5):2241-51. PubMed ID: 23365075 [Abstract] [Full Text] [Related]
39. Mutated tau, amyloid and neuroinflammation in Alzheimer disease-A brief review. Hung AS, Liang Y, Chow TC, Tang HC, Wu SL, Wai MS, Yew DT. Prog Histochem Cytochem; 2016 May 01; 51(1):1-8. PubMed ID: 26851150 [Abstract] [Full Text] [Related]
40. Hyperspectral Raman imaging of neuritic plaques and neurofibrillary tangles in brain tissue from Alzheimer's disease patients. Michael R, Lenferink A, Vrensen GFJM, Gelpi E, Barraquer RI, Otto C. Sci Rep; 2017 Nov 15; 7(1):15603. PubMed ID: 29142266 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]